Staar Surgical reported $202.49M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Atrion ATRI:US 16.44M 15.83M
Cerus CERS:US $ 32.31M 6.06M
Cooper Companies COO:US $ 399.2M 118.5M
Exact Sciences EXAS:US $ 56.2M 1.75M
Hologic HOLX:US $ 2375.3M 84.5M
Meridian Bioscience VIVO:US $ 83.49M 82.47M
Merit Medical Systems MMSI:US $ 63M 9.13M
Novartis NOVN:VX SF 3625M 10227M
Orasure Technologies OSUR:US $ 66.16M 4.56M
Orthofix International OFIX:US $ 59.54M 12.38M
Sientra SIEN:US $ 38.88M 12.89M
Staar Surgical STAA:US $ 202.49M 9.42M
Utah Medical Products UTMD:US $ 66.22M 1.9M
Valeant Pharmaceuticals VRX:CN $ 1249M 667M